New ACIP Panel Votes to Recommend Clesrovimab, Second Antibody to Prevent RSV in Infants

The seven newly appointed members of ACIP voted 5-to-2 to recommend Enflonsia, the second long-acting monoclonal antibody administered to infants to prevent RSV infection.